A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Conditions
Sjögren · Sjogren Disease · Sjogren's Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cullinan Investigative Site, Orlando, Florida, United States
Cullinan Investigative Site, Memphis, Tennessee, United States
Cullinan Investigative Site, Plano, Texas, United States
Cullinan Investigative Site, Webster, Texas, United States
Cullinan Investigative Site, Salt Lake City, Utah, United States
Cullinan Investigative Site, Brest, France
Cullinan Investigative Site, Le Kremlin-Bicêtre, France
Cullinan Investigative Site, Strasbourg, France
Cullinan Investigative Site, Erlangen, Germany
Cullinan Investigative Site, Hanover, Germany
Cullinan Investigative Site, Roma, Italy